Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...

February is Age-Related Macular Degeneration Awareness (AMD) month. While AMD might be unfamiliar to some, nearly half a million people in Quebec are affected by this disease, which is the leading ...

Jefferies analyst issued a revised price target for 4D Molecular Therapeutics (NASDAQ:FDMT) stock, lowering it to $40 from the previous $51, while maintaining a Buy rating. Currently trading at $5.48, ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

As people get older, two of the biggest health concerns are dementia and eye diseases like macular degeneration and cataracts ...

For those who smoke, this long-term habit can damage parts of your eye, contributing to serious conditions such as macular ...

The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...

Bayer submitted an application to the European Medicines Agency (EMA) to expand treatment intervals of up to 6 months with Eylea™ 8 mg (aflibercept 8 mg, ...

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.